Get $5 off $25+ with SAVE5

FIND A STORE NEAR YOU

Clinical white paper

Stress Less: formulation and evidence review

This page is a condensed, citation-preserving summary of the full white paper; the PDF is the complete document.

By Matt Crane, PhD, Co-Founder & Chief Science Officer · Last reviewed July 2026

Executive summary

We designed Stress Less to support stress management, relaxation, sleep quality, cellular energy, and exercise recovery with taurine and standardized lemon balm.[11][24][27][44] Women experience distinct stress burdens, hormonal contexts, and sleep patterns, which informed our women-centered perspective.[1][6][7][8]

Each serving provides 2 g taurine, within doses used in human research, and 10 mg standardized lemon balm extract.[13][25][28] Published ingredient evidence does not establish an effect of the finished formula.

Formulation rationale

Why we combined taurine and lemon balm

We chose taurine because it participates in nervous-system, cardiovascular, mitochondrial, and exercise physiology.[11][24][27] Meta-analyses of controlled human trials report changes in metabolic, inflammatory, and oxidative-stress markers, although these outcomes are not direct tests of daily perceived stress.[13][14][15] We selected 2 g per serving because this amount sits within studied human ranges.[13][25][28]

We added 10 mg standardized lemon balm for complementary calming support. Human and review literature evaluates lemon balm for psychological well-being, mood, and cognition, while laboratory studies describe GABA-transaminase inhibition as a possible mechanism.[44][45][46][48]

Formula and dose rationale at a glance

IngredientForm / amountRole in the formula
Taurine 2 g per serving Nervous-system, mitochondrial, metabolic, and exercise-recovery support; amount aligns with human research doses
Lemon balm extract 10 mg standardized extract per serving Complementary support for calm and psychological well-being

See current product facts

Published literature

The evidence we used

Our review includes epidemiology, systematic reviews, controlled trials, mechanistic work, and preclinical aging research. We give human evidence priority and do not translate animal longevity findings into a human product claim.[13][25][38]

  • Stress contextEpidemiology and reviews

    Stress, caregiving, hormonal context, and sleep differ across women's lives.[1][6][7][8]

  • Taurine and metabolic markersMeta-analyses

    Controlled-trial meta-analyses evaluated metabolic, inflammatory, and oxidative-stress biomarkers.[13][14][15]

  • Mitochondria and recoveryReview and human trials

    Taurine has mechanistic roles in mitochondria and has been tested in exercise and recovery settings.[24][28][32]

  • Lemon balmReview, human, and mechanism

    Published work evaluates psychological well-being, acute mood/cognition, and GABA-related mechanisms.[44][45][46][48]

Finished-formula evidence

Strongest published human evidence

Stress Less has no Semaine-funded finished-formula study, so we highlight the strongest published human evidence without presenting it as a test of this product. A 2024 systematic review and meta-analysis pooled randomized controlled trials of taurine and metabolic-syndrome outcomes, while a 2022 dose-response meta-analysis evaluated inflammatory and oxidative-stress biomarkers.[13][15] Double-blind, placebo-controlled studies also evaluated taurine in oxidative-stress and inflammation settings, and a 2024 review assessed lemon balm's clinical efficacy and tolerability for psychological well-being.[25][26][44] Different populations, endpoints, doses, and preparations limit direct application to the finished gummy.

Funding disclosure: There is no Semaine-funded finished-formula study for Stress Less; this section summarizes independently published ingredient research.

See our clinical studies

Full references

  1. American Psychological Association. Stress in America 2021.
  2. Mariotti A. Future Sci OA. 2015;1:FSO23.
  3. Slavich GM, Irwin MR. Psychol Bull. 2014;140:774-815.
  4. Mosca L, et al. Circulation. 2011;124:2145-2154.
  5. Albert PR. J Psychiatry Neurosci. 2015;40:219-221.
  6. Caputo J, et al. J Marriage Fam. 2016;78:1382-1398.
  7. Abel KM, Kulkarni J. Depression in women: Hormonal influences. Cambridge UP; 2006.
  8. Krishnan V, Collop NA. Curr Opin Pulm Med. 2006;12:383-389.
  9. Lee EL, et al. Drug Saf. 2022;45:713-735.
  10. Barnes PM, et al. US complementary medicine use report. 2008.
  11. Ripps H, Shen W. Mol Vis. 2012;18:2673-2686.
  12. Ha CR, et al. Adv Exp Med Biol. 2015;803:725-733.
  13. Tzang CC, et al. Nutr Diabetes. 2024;14:29.
  14. Tao X, et al. Food Chem. 2022;4:100106.
  15. Faghfouri AH, et al. Eur J Clin Nutr. 2022;76:647-658.
  16. Park JY, et al. J Biomed Sci. 2010;17 Suppl 1:S40.
  17. Oja SS, Saransaari P. Adv Exp Med Biol. 2022;1370:325-331.
  18. Oja SS, Saransaari P. Epilepsy Res. 2013;104:187-194.
  19. Jangra A, et al. Neural Regen Res. 2024;19:62-68.
  20. Mezzomo NJ, et al. Horm Behav. 2019;109:44-52.
  21. Albrecht J, Schousboe A. Neurochem Res. 2005;30:1615-1621.
  22. Ochoa-de la Paz L, et al. Expert Rev Neurother. 2019;19:289-291.
  23. El Idrissi A, Trenkner E. Neurochem Res. 2004;29:189-197.
  24. Jong CJ, et al. Molecules. 2021;26.
  25. Rosa FT, et al. Eur J Nutr. 2014;53:823-830.
  26. Maleki V, et al. Diabetol Metab Syndr. 2020;12:9.
  27. Kurtz JA, et al. J Int Soc Sports Nutr. 2021;18:39.
  28. Rutherford JA, et al. Int J Sport Nutr Exerc Metab. 2010;20:322-329.
  29. Carvalho MB, et al. Nutrients. 2020;12:1540.
  30. Waldron M, et al. Amino Acids. 2019;51:1433-1441.
  31. De Carvalho FG, et al. Front Physiol. 2017;8.
  32. Chupel MU, et al. Amino Acids. 2021;53:333-345.
  33. Yamori Y, et al. Adv Exp Med Biol. 2009;643:13-25.
  34. Domoto T, et al. Front Nutr. 2024;11.
  35. Yamori Y, et al. J Biomed Sci. 2010;17 Suppl 1:S6.
  36. Yamori Y, et al. Hypertens Res. 2001;24:453-457.
  37. Schaffer SW, et al. Amino Acids. 2014;46:1147-1157.
  38. Fernandez ME, et al. Science. 2025;388:eadl2116.
  39. Guan C, et al. bioRxiv. 2025. doi:10.1101/2025.05.27.656381.
  40. Vandanmagsar B, et al. Nat Med. 2011;17:179-188.
  41. Singh P, et al. Science. 2023;380:eabn9257.
  42. Shao A, Hathcock JN. Regul Toxicol Pharmacol. 2008;50:376-399.
  43. European Medicines Agency. Assessment report on Melissa officinalis L. 2012.
  44. Mathews IM, et al. Nutrients. 2024;16:3545.
  45. Awad R, et al. Can J Physiol Pharmacol. 2007;85:933-942.
  46. Kennedy DO, et al. Neuropsychopharmacology. 2003;28:1871-1881.
  47. Savage K, et al. Phytother Res. 2018;32:3-18.
  48. Awad R, et al. Phytother Res. 2009;23:1075-1081.
Read the full white paper (PDF)View the clinical evidenceSee current product facts

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Your Cart
Taxes and shipping calculated at checkout